155 related articles for article (PubMed ID: 1931234)
1. Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells.
Warner JF; Anderson CG; Laube L; Jolly DJ; Townsend K; Chada S; St Louis D
AIDS Res Hum Retroviruses; 1991 Aug; 7(8):645-55. PubMed ID: 1931234
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.
Laube LS; Burrascano M; Dejesus CE; Howard BD; Johnson MA; Lee WT; Lynn AE; Peters G; Ronlov GS; Townsend KS
Hum Gene Ther; 1994 Jul; 5(7):853-62. PubMed ID: 7981310
[TBL] [Abstract][Full Text] [Related]
3. Induction of anti-HIV-1 immune responses by retroviral vectors.
Jolly DJ; Warner JF
Biotechnol Ther; 1991; 2(1-2):179-93. PubMed ID: 1845120
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes.
Chada S; DeJesus CE; Townsend K; Lee WT; Laube L; Jolly DJ; Chang SM; Warner JF
J Virol; 1993 Jun; 67(6):3409-17. PubMed ID: 8497058
[TBL] [Abstract][Full Text] [Related]
6. Efficient antigen presentation to cytotoxic T lymphocytes by cells transduced with a retroviral vector expressing the HIV-1 Nef protein.
Robertson MN; Buseyne F; Schwartz O; Rivière Y
AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1217-23. PubMed ID: 7511396
[TBL] [Abstract][Full Text] [Related]
7. Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates.
Irwin MJ; Laube LS; Lee V; Austin M; Chada S; Anderson CG; Townsend K; Jolly DJ; Warner JF
J Virol; 1994 Aug; 68(8):5036-44. PubMed ID: 8035504
[TBL] [Abstract][Full Text] [Related]
8. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
[TBL] [Abstract][Full Text] [Related]
9. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.
Fuller DH; Haynes JR
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1433-41. PubMed ID: 7888198
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
Bergmann CC; Tong L; Cua RV; Sensintaffar JL; Stohlman SA
J Immunol; 1994 Jun; 152(12):5603-12. PubMed ID: 7515908
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1.
Casement KS; Nehete PN; Arlinghaus RB; Sastry KJ
Virology; 1995 Aug; 211(1):261-7. PubMed ID: 7645219
[TBL] [Abstract][Full Text] [Related]
12. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
Doe B; Steimer KS; Walker CM
Eur J Immunol; 1994 Oct; 24(10):2369-76. PubMed ID: 7523139
[TBL] [Abstract][Full Text] [Related]
13. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
Ahlers JD; Pendleton CD; Dunlop N; Minassian A; Nara PL; Berzofsky JA
J Immunol; 1993 Jun; 150(12):5647-65. PubMed ID: 8515081
[TBL] [Abstract][Full Text] [Related]
14. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
AIDS Vaccine Evaluation Group 022 Protocol Team
J Infect Dis; 2001 Feb; 183(4):563-70. PubMed ID: 11170981
[TBL] [Abstract][Full Text] [Related]
15. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.
Bergmann C; Stohlmann SA; McMillan M
Eur J Immunol; 1993 Nov; 23(11):2777-81. PubMed ID: 7693478
[TBL] [Abstract][Full Text] [Related]
16. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo.
Nakagawa Y; Shimizu M; Norose Y; Takahashi M; Takahashi H
Int Immunol; 2013 Jan; 25(1):11-24. PubMed ID: 22945875
[TBL] [Abstract][Full Text] [Related]
17. Accell particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses.
Haynes JR; Fuller DH; Eisenbraun MD; Ford MJ; Pertmer TM
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S43-5. PubMed ID: 7865332
[TBL] [Abstract][Full Text] [Related]
18. A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice.
Buffa V; Negri DRM; Leone P; Bona R; Borghi M; Bacigalupo I; Carlei D; Sgadari C; Ensoli B; Cara A
J Gen Virol; 2006 Jun; 87(Pt 6):1625-1634. PubMed ID: 16690927
[TBL] [Abstract][Full Text] [Related]
19. A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes.
Lorin C; Delebecque F; Labrousse V; Da Silva L; Lemonnier F; Brahic M; Tangy F
Vaccine; 2005 Aug; 23(36):4463-72. PubMed ID: 15993518
[TBL] [Abstract][Full Text] [Related]
20. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
